Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Blood Advances
|
August 12, 2025
Overcoming venetoclax resistance through heme-mediated NOXA/cyclin D1/Mcl-1 axis with a novel artemisinin conjugate
Jingyi Zhang, Zhenwei Zhang, Jinghua Liu, et al.
Blood
|
November 13, 2007
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia
Annegret Glasow, Angela Barrett, Kevin Petrie, et al.
Hepatology (Baltimore, Md.)
|
March 30, 2007
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
Elisa Wurmbach, Ying-bei Chen, Greg Khitrov, et al.
The Journal of Clinical Investigation
|
February 18, 2009
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
Byoung Kwon Yoo, Luni Emdad, Zao-zhong Su, et al.
Blood
|
January 25, 2002
Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk
Qi Zhu, Ji-Wang Zhang, Hai-Qing Zhu, et al.
Gastroenterology
|
November 8, 2006
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
Josep M Llovet, Yingbei Chen, Elisa Wurmbach, et al.
Blood
|
December 25, 2007
The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor
Jotin Marango, Manabu Shimoyama, Hitomi Nishio, et al.
Oncotarget
|
October 14, 2015
Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
Nidhi Bansal, Kevin Petrie, Rossitza Christova, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 4, 2011
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models
Konstantin H Dragnev, Tian Ma, Jobin Cyrus, et al.
Gastroenterology
|
February 18, 2011
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a
Sara Toffanin, Yujin Hoshida, Anja Lachenmayer, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Blood Advances
|
August 12, 2025
Overcoming venetoclax resistance through heme-mediated NOXA/cyclin D1/Mcl-1 axis with a novel artemisinin conjugate
Jingyi Zhang, Zhenwei Zhang, Jinghua Liu, et al.
Blood
|
November 13, 2007
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia
Annegret Glasow, Angela Barrett, Kevin Petrie, et al.
Hepatology (Baltimore, Md.)
|
March 30, 2007
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
Elisa Wurmbach, Ying-bei Chen, Greg Khitrov, et al.
The Journal of Clinical Investigation
|
February 18, 2009
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
Byoung Kwon Yoo, Luni Emdad, Zao-zhong Su, et al.
Blood
|
January 25, 2002
Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk
Qi Zhu, Ji-Wang Zhang, Hai-Qing Zhu, et al.
Gastroenterology
|
November 8, 2006
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
Josep M Llovet, Yingbei Chen, Elisa Wurmbach, et al.
Blood
|
December 25, 2007
The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor
Jotin Marango, Manabu Shimoyama, Hitomi Nishio, et al.
Oncotarget
|
October 14, 2015
Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
Nidhi Bansal, Kevin Petrie, Rossitza Christova, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 4, 2011
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models
Konstantin H Dragnev, Tian Ma, Jobin Cyrus, et al.
Gastroenterology
|
February 18, 2011
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a
Sara Toffanin, Yujin Hoshida, Anja Lachenmayer, et al.
Page
of 8